Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yu-Chuan-San is a topical traditional Chinese medicine (TCM) formulation developed by Beijing Shijitan Hospital Affiliated to Capital Medical University for the treatment of mild recurrent aphthous ulcers (canker sores). Formulated as a powder (indicated by the suffix 'San'), it is applied directly to the oral mucosa to provide rapid analgesia and promote the healing of ulcerated lesions. In clinical research, including a randomized controlled trial (ChiCTR2000038691), Yu-Chuan-San has been evaluated for its analgesic intensity, effective rate, and impact on ulcer area compared to established treatments like Tongrentang oral ulcer powder. As a multi-ingredient herbal preparation, its therapeutic effects are attributed to the synergistic anti-inflammatory and mucosal protective properties of its botanical components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yu-Chuan-San.